How do we interpret the results?

J. Roca (Barcelona, Spain)

Source: Annual Congress 2006 - Blood gas workshop
Session: Blood gas workshop
Session type: Symposium
Number: 2061

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Roca (Barcelona, Spain). How do we interpret the results?. Annual Congress 2006 - Blood gas workshop

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How do we interpret the sample data?
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014




How to interpret microbiological results
Source: International Congress 2014 – PG08 The management of non-CF bronchiectasis: from childhood to adulthood
Year: 2014




What have we learn from rebiospy studies?
Source: ERS Research Seminar
Year: 2015


How to share the results of pulmonary function testing with clinicians?
Source: Eur Respir J 2006; 28: Suppl. 50, 863s
Year: 2006

Is there a need for ongoing support for the interpretation of spirometry results by general practitioners?
Source: Eur Respir J 2006; 28: Suppl. 50, 740s
Year: 2006

When to apply which bronchial challenge test and interpretation of the results
Source: Annual Congress 2013 –New ATS/ERS recommendations for bronchial challenge testing
Year: 2013

How can real-world data be used to improve outcomes?
Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Year: 2021



The way forward: how to link real-life situations and clinical trial results
Source: Annual Congress 2013 - Lunchtime Session "Tiotropium soft mist inhaler and mortality in COPD: results of the TIOSPIR clinical trial"
Year: 2013

Why don't patients follow the rules? Understanding the motivation behind behavioural change
Source: Annual Congress 2013 –PG8 How to encourage compliance with therapy
Year: 2013


What makes large epidemiological studies comparable?
Source: Eur Respir J 2010; 36: 720-721
Year: 2010


New methods: what do they tell us? Fluctuation analysis of lung function
Source: Eur Respir Mon; 2010: 47: 310–324
Year: 2010

Are estimations of radiomic image markers dispensable due to recent deep learning findings?
Source: Eur Respir J, 54 (2) 1901185; 10.1183/13993003.01185-2019
Year: 2019



COVID-19 phenotypes: leading or misleading?
Source: Eur Respir J, 56 (2) 2002195; 10.1183/13993003.02195-2020
Year: 2020